Related Experiment Videos
cDNA microarray analysis of gene expression in pathologic Stage IA nonsmall cell lung carcinomas
Haruhiko Nakamura1, Hisashi Saji, Akihiko Ogata
1Department of Surgery, Tokyo Medical University, Japan. hanakamu@tokyo-med.ac.jp
Cancer
|May 27, 2003
Summary
Altered gene expression is common in early-stage nonsmall cell lung carcinoma. This study used cDNA microarrays to identify numerous gene expression differences in Stage IA lung cancer specimens.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- The link between gene expression changes and lung carcinoma progression is not well understood.
- Early-stage lung cancer gene expression requires further characterization.
Purpose of the Study:
- To analyze gene expression profiles in early-stage nonsmall cell lung carcinoma (NSCLC).
- To identify specific gene expression alterations in pathologic Stage IA NSCLC.
Main Methods:
- Utilized cDNA microarray analysis on surgical specimens from NSCLC patients.
- Compared gene expression in tumor tissues versus adjacent normal lung tissues.
- Quantified gene expression using tumor-to-normal fluorescence ratios (T:N ratio).
Main Results:
- Identified significant gene expression alterations in early-stage NSCLC.
- Found 40 overexpressed and 74 underexpressed genes among 425 evaluated.
- Observed differential expression in 30 genes in Stage IA tumors compared to advanced stages.
Conclusions:
- cDNA microarray analysis revealed widespread gene expression alterations in early NSCLC.
- These findings highlight the molecular heterogeneity of early-stage lung cancer.